Search - tctmd.com

Displaying 61 - 80 of 181

Sort: Relevancy | Date

Presentation TVT 2023

Transapical Mechanical Splitting of the AML to Prevent LVOT Obstruction Before TMVR: FIH Experience

Presenter: Danny Dvir

June 10, 2023

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

Presentation TVT 2023

LVOT Obstruction and TMVR – Predictors, Evaluation and Solutions

Presenter: Jaffar Khan

June 09, 2023

Presentation TVT 2023

A challenging case of concomitant severe AS and LVOT obstruction in the setting of HOCM

Presenter: samineh sehatbakhsh

June 08, 2023

Presentation TVT 2023

Valve-in-MAC (Sizing, Risk Assessment for LVOTO)

Presenter: Mark Lebehn

June 07, 2023

Presentation TVT 2023

TMVR and Lampoon vs Sesame (Risk Assessment for LVOTO)

Presenter: Mark Lebehn

June 07, 2023

News Conference News EuroPCR 2023

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

Caitlin E. Cox

May 19, 2023

News Conference News HFSA 2022

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

L.A. McKeown

October 07, 2022

Presentation TCT 2022

TCT 642: Threading the Needle - A Challenging Case of TAVR in a Patient with an LVOT Protruding Balloon-Expandable TMVR

Presenter: Giorgio Medranda

September 19, 2022

Presentation TCT 2022

Trans-Apical Mechanical Splitting of the Anterior Mitral Leaflet to Prevent LVOT Obstruction Before TMVR: FIH Experience With the SHORTCUT Device

Presenter: Paolo Denti

September 19, 2022

Presentation TCT 2022

CT Imaging for TMVR Planning: Predictors of LVOT Obstruction and Implications for Device Selection

Presenter: Philipp Blanke

September 19, 2022

Presentation TCT 2022

LVOT Obstruction: Prediction Models and Emerging Prevention Techniques

Presenter: Mayra Guerrero

September 18, 2022

Presentation TCT 2022

Outcomes of Mitral Regurgitation Patients Screen Failed for LVOT Obstruction Treated Using Altavalve

Presenter: Vinayak N. Bapat

September 18, 2022

Presentation Interventional Complications 2022

LVOT obstruction post TMVR

Presenter: Adam Greenbaum

July 15, 2022

Presentation TVT 2022

LVOT Obstruction Post-TMVR: Predictors, Prevention, and Post-interventional Management

Presenter: Vinayak N. Bapat

June 10, 2022

Presentation TVT 2022

Mitral Transcatheter Edge-to-Edge Repair for Dynamic LVOT Obstruction

Presenter: Tim Hinohara

June 10, 2022

Presentation TVT 2022

#2 Case Resolution: Acute LVOT Obstruction Post-TMVR

Presenter: Adam Greenbaum

June 08, 2022

Presentation TVT 2022

#2 Case Presentation: Acute LVOT Obstruction Post-TMVR

Presenter: Adam Greenbaum

June 08, 2022

News Conference News ESC Heart Failure 2022

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

Todd Neale

May 31, 2022

News Conference News ACC 2022

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

Shelley Wood

April 03, 2022

Advertisement

Transapical Mechanical Splitting of the AML to Prevent LVOT Obstruction Before TMVR: FIH Experience

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

LVOT Obstruction and TMVR – Predictors, Evaluation and Solutions

A challenging case of concomitant severe AS and LVOT obstruction in the setting of HOCM

Valve-in-MAC (Sizing, Risk Assessment for LVOTO)

TMVR and Lampoon vs Sesame (Risk Assessment for LVOTO)

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

TCT 642: Threading the Needle - A Challenging Case of TAVR in a Patient with an LVOT Protruding Balloon-Expandable TMVR

Trans-Apical Mechanical Splitting of the Anterior Mitral Leaflet to Prevent LVOT Obstruction Before TMVR: FIH Experience With the SHORTCUT Device

CT Imaging for TMVR Planning: Predictors of LVOT Obstruction and Implications for Device Selection

LVOT Obstruction: Prediction Models and Emerging Prevention Techniques

Outcomes of Mitral Regurgitation Patients Screen Failed for LVOT Obstruction Treated Using Altavalve

LVOT obstruction post TMVR

LVOT Obstruction Post-TMVR: Predictors, Prevention, and Post-interventional Management

Mitral Transcatheter Edge-to-Edge Repair for Dynamic LVOT Obstruction

#2 Case Resolution: Acute LVOT Obstruction Post-TMVR

#2 Case Presentation: Acute LVOT Obstruction Post-TMVR

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content